Accelink Accounts Payable from 2010 to 2024

002281 Stock   42.58  1.91  4.70%   
Accelink Technologies' Accounts Payable is increasing over the years with slightly volatile fluctuation. Accounts Payable is expected to dwindle to about 1.4 B. Accounts Payable is the amount Accelink Technologies Co owes to suppliers or vendors for products or services received but not yet paid for. It represents Accelink Technologies' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2008-12-31
Previous Quarter
B
Current Value
3.5 B
Quarterly Volatility
884.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Accelink Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Accelink Technologies' main balance sheet or income statement drivers, such as Interest Expense of 12.1 M, Selling General Administrative of 166.4 M or Total Revenue of 4 B, as well as many indicators such as . Accelink financial statements analysis is a perfect complement when working with Accelink Technologies Valuation or Volatility modules.
  
This module can also supplement various Accelink Technologies Technical models . Check out the analysis of Accelink Technologies Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Accelink Stock

Accelink Technologies financial ratios help investors to determine whether Accelink Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Accelink with respect to the benefits of owning Accelink Technologies security.